相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

如何治疗严重的Acinetobacter baumannii感染

Emilio Bouza^1,2,3,4, Patricia Muñoz^1,2,3,4, Almudena Burillo^1,2,3

¹Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón.

Current opinion in infectious diseases

|November 6, 2023

概括

由于抗菌素耐药性,管理严重的Acinetobacter baumannii感染 (ABI) 是一个挑战. 新的药物和菌体疗法对治疗这些难以治疗的细菌感染有希望.

科学领域:

微生物学微生物学
传染性疾病传染性疾病
抗微生物耐药性抗微生物耐药性

背景情况:

严重的Acinetobacter baumannii感染 (ABI) 是一个重大的临床挑战.
多抗性Acinetobacter baumannii分离物越来越普遍,复杂化了治疗选择.

研究的目的:

提供关于严重的Acinetobacter baumannii感染的管理策略的最新审查.
突出新兴的治疗选择和挑战,以治疗由多抗性Acinetobacter baumannii引起的感染.

主要方法:

对抗Acinetobacter baumannii的抗微生物活性现有文献的审查.
对治疗指南和新兴治疗剂的分析.
探索替代治疗方式,如菌体治疗.

主要成果:

许多抗微生物药物对ABI的体外活性是可变的,并且正在下降.
经常建议进行组合治疗,理想情况下是两种一线药物.
新的药物如Cefiderocol,Sulbactam/Durlobactam和新型的四环素需要进一步的临床验证.

结论:

治疗严重的ABI,特别是来自耐药菌株的ABI,需要仔细考虑现有和新兴的抗菌选择.
菌体治疗是一种有前途的替代抗生素,用于Acinetobacter baumannii感染.
需要继续进行研究,以确定新药和替代疗法的疗效.

更多相关视频

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Published on: August 4, 2023

Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

Published on: April 10, 2020

相关概念视频

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...